Rapid genetic MT-RNR1 test for neonates preventing hearing loss

Preliminary market consultation to inform the NHS commercial strategy for rapid genetic MT-RNR1 test for neonates preventing hearing loss. Please note all stated financial values in relation to this notice are nominal, as the financial envelope is yet to be defined. Projected contracting dates in the notice, similarly do not reflect any plans as these are yet to be defined. To express interest, review and respond to the request for information questionnaire please register and apply via Atamis e-sourcing portal usi...